Premium
SU‐C‐204‐01: A Dosimetric Investigation Into the Effects of Yttrium‐90 Radioembolization On the GI Tract: In‐Vivo and Histological Analysis in An Animal Model
Author(s) -
Pasciak A,
Nodit L,
Bourgeois A,
Paxton B,
Arepally A,
Bradley Y
Publication year - 2016
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.4955525
Subject(s) - medicine , stomach , nuclear medicine , microsphere , gastrointestinal tract , radiology , dosimetry , gastroenterology , engineering , chemical engineering
Purpose: In Yttrium‐90 (90Y) radioembolization, non‐target embolization (NTE) to the stomach or small bowel can result in ulceration, a rare but difficult to manage clinical complication. However, dosimetric thresholds for toxicity to these tissues from radioembolization have never been evaluated in a controlled setting. We performed an analysis of the effect of 90Y radioembolization in a porcine model at different absorbed‐dose endpoints. Methods: Under approval of the University of Tennessee IACUC, 6 female pigs were included in this study. Animals underwent transfemoral angiography and infusion of calibrated dosages of 90Y resin microspheres into arteries supplying part of the gastric wall. A 99mTc‐MAA simulation study was performed first to determine perfused tissue volume for treatment planning along with contrast‐enhanced CT. The pigs were monitored for side effects for 9 weeks, after which time they were euthanized and their upper gastrointestinal tracts were harvested for analysis. Results: 90Y radioembolization was infused resulting in average absorbed doses of between 35.5 and 91.9 Gy to the gastric wall. No animal exhibited any signs of pain or gastrointestinal distress through the duration of the study. Excised tissue showed 1–2 small (<3.0 cm2) healed or healing superficial gastric lesions in 5 out of 6 animals. Histologic analysis demonstrated that lesion location was superficial to areas of abnormally high microsphere deposition. An analysis of microsphere deposition patterns within the gastric wall indicated a high preference for submucosal deposition. Dosimetric evaluation at the luminal mucosa performed based on microsphere deposition patterns confirmed that 90Y dosimetry techniques conventionally used in hepatic dosimetry provide a reasonable estimate of absorbed dose. Conclusion: The upper gastrointestinal tract may be less sensitive to 90Y radioembolization than previously thought. Lack of charged‐particle equilibrium at the luminal mucosa may contribute to decreased toxicity of 90Y radioembolization compared to external‐beam radiation therapy in gastrointestinal tissue. This project was supported by SIRTex Medical Ltd